Russell Investments Group’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Russell Investments Group’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4	Closed	-$351	–	3803
2024 Q3	$351	Hold	4	–	–	﹤0.01%	3601
2024 Q2	$368	Hold	4	–	–	﹤0.01%	3520
2024 Q1	$574	Hold	4	–	–	﹤0.01%	3191
2023 Q4	$435	Hold	4	–	–	﹤0.01%	3134
2023 Q3	$748	Hold	4	–	–	﹤0.01%	3365
2023 Q2	$759	Hold	4	–	–	﹤0.01%	3339
2023 Q1	$575	Hold	4	–	–	﹤0.01%	3095
2022 Q4	$506	Hold	4	–	–	﹤0.01%	2882
2022 Q3	$0	Hold	4	–	–	﹤0.01%	2984
2022 Q2	$1K	Hold	4	–	–	﹤0.01%	2871
2022 Q1	$2K	Hold	4	–	–	﹤0.01%	2730
2021 Q4	$3K	Hold	4	–	–	﹤0.01%	2986
2021 Q3	$4K	Hold	4	–	–	﹤0.01%	3019
2021 Q2	$11K	Hold	4	–	–	﹤0.01%	3187
2021 Q1	$23K	Sell	4 -32	-89%	-$232K	﹤0.01%	3063
2020 Q4	$205K	Buy	36 +30	+500%	+$189K	﹤0.01%	2750
2020 Q3	$36K	Buy	6 +2	+50%	+$11.7K	﹤0.01%	3105
2020 Q2	$22K	Hold	4	–	–	﹤0.01%	3050
2020 Q1	$38K	Sell	4 -4	-50%	-$62.7K	﹤0.01%	2900
2019 Q4	$133K	Sell	8 -1	-11%	-$16.7K	﹤0.01%	2823
2019 Q3	$153K	Sell	9 -4	-31%	-$64.6K	﹤0.01%	2704
2019 Q2	$286K	Buy	13 +1	+8%	+$24.7K	﹤0.01%	2429
2019 Q1	$330K	Buy	12 +1	+9%	+$24K	﹤0.01%	2477
2018 Q4	$162K	Buy	+11	New	+$246K	﹤0.01%	2637

Other funds holding YARW

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

EAM

Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Russell Investments Group's YARW Position: Q4 2024 in Review

Russell Investments Group sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q4 2024, closing a stake of 4 shares — an estimated $351 sold.

Russell Investments Group first reported a position in YARW in Q4 2018 and held it in 24 quarters. The position peaked at $330K in Q1 2019. 34 funds tracked by Wall St. Rank hold YARW as of Q4 2024.

Russell Investments Group reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Russell Investments Group sold 4 Yarrow Bioscience, Inc. Common Stock shares in Q4 2024, an estimated $351.
Russell Investments Group first reported a position in Yarrow Bioscience, Inc. Common Stock in Q4 2018 and held it in 24 quarters.
Russell Investments Group's Yarrow Bioscience, Inc. Common Stock position peaked at $330K in Q1 2019.
34 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q4 2024.

Based on Russell Investments Group's 13F filing for Q4 2024, filed 13 Feb 2025.